Group 1 - India has proposed a "zero-for-zero" tariff arrangement for specific goods, including steel, auto parts, and pharmaceuticals, during trade negotiations with the US, based on reciprocity and limited to a certain quantity of imports [1][2] - The US has expressed concerns regarding India's quality control regulations, viewing them as non-tariff trade barriers that restrict market access for American companies [1][2] - India's exports of pharmaceuticals to the US are valued at $10.5 billion, while engineering products exports amount to $19.1 billion in the new fiscal year [1] Group 2 - The proposal for "zero-for-zero" tariffs has garnered attention, but it is unlikely to be adopted due to differing economic development levels between the US and India [2] - The number of quality control orders in India has increased significantly from 14 before 2014 to over 140 since 2017, raising transparency and fairness concerns [2] - President Trump claimed that India agreed to reduce tariffs on US imports to "zero," although India has not officially confirmed this statement as negotiations are ongoing [3]
美媒爆：印美关税谈判，印度提出特定商品“零换零”
Huan Qiu Shi Bao·2025-05-07 22:42